GTR 107290913
Bids Are Invited For Registration Of Prices For Possible Acquisition Of Medicines, Exclusively For Me/Epp
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
107290913
Tendering Authority
Subscribe to view
Tender No
12/2025-SRP/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For Possible Acquisition Of Medicines, Exclusively For Me/Epp
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
22-01-2026
Closed
Work Detail
Acetylsalicylic Acid. Concentration: 100 Mg. Pharmaceutical Form: Enteral Release Tablet. Presentation: Unit., Gamaminobutyric Acid 50Mg + L-Lysine 50Mg + Thiamine 2Mg + Pyridoxine 4Mg + Calcium Pantothenate 4Mg, Pharmaceutical Form: Tablet. Presentation: Unit., Tranexamic Acid. Concentration: 250 Mg. Pharmaceutical Form: Tablet Presentation: Unit., Alogliptin + Metformin. Concentration: 12.5Mg + 1000Mg, Bisoprolol, Fumarate. Concentration: 5 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., 01/09/2026 - 20:10:42, Fumarate. Concentration: 2.5 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Candesartan Cilexetil + Hydrochlorothiazide, Concentration: 16Mg + 12.5Mg, Presentation: Unit., Cholecalciferol (Vitamin D3). Concentration: 5,000 Iu. Pharmaceutical Form: Tablet. Presentation: Unit, Cholecalciferol (Vitamin D3). Concentration: 7,000 Iu. Pharmaceutical Form: Tablet. Presentation: Unit, Diosmin Associated With Hesperidin. Concentration: 900 Mg + 100 Mg. Pharmaceutical Form: Coated Tablet. Presentation: Unit., Diosmin Associated With Hesperidin.Concentration: 900 Mg + 100 Mg. Pharmaceutical Form: Granules. Presentation: Sachet Containing 5 G, Divalproex Sodium, Concentration: 500 Mg. Pharmaceutical Form: Extended Release Tablet. Presentation: Unit., Duloxetine, Hydrochloride. Concentration: 60Mg. Pharmaceutical Form: Delayed Release Capsule. Presentation: Unit., Esomeprazole, Magnesium. Concentration: 40 Mg. Pharmaceutical Form: Controlled Release Tablet. Presentation: Unit., Fluticasone, Furoate Associated With Vilanterol, Trifenatate. Concentration: 200/25 Mcg. Pharmaceutical Form: Powder For Oral Inhalation. Presentation: Inhaler Bottle Containing 30 Doses/Unit, Hydralazine, Hydrochloride. Concentration: 25 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Insulin Glulisine. Concentration: 100 Iu/Ml. Pharmaceutical Form: Injectable Solution. Presentation: Pen With Application System Containing 3Ml. Presentation: Unit., Insulin Glargine, Concentration: 100 Iu/Ml. Pharmaceutical Form: Injectable Solution. Presentation: Pen With Application System Containing 3Ml., Isosorbide, Dinitrate. Concentration: 5 Mg. Pharmaceutical Form: Sublingual Tablet. Presentation: Unit., Mononitrate. Concentration: 50 Mg. Pharmaceutical Form: Controlled Release Capsule. Presentation: Unit., Ivabradine, Hydrochloride. Concentration: 5 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Levetiracetam, Concentration: 500 Mg Pharmaceutical Form: Tablet. Presentation: Unit., Levanlodipine, Besylate. Concentration: 2, Pantoprazole. Concentration: 20 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Pantoprazole. Concentration: 40 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Propatylnitrate. Concentration: 10 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Quetiapine, Fumarate. Concentration: 50 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Fumarate. Concentration: 100 Mg. Pharmaceutical Form: Tablet. Presentation: Unit., Rosuvastatin Calcium. Concentration: 20 Mg. Pharmaceutical Form: Coated Tablet. Presentation: Unit., Rosuvastatin Calcium. Concentration: 40 Mg. Pharmaceutical Form: Coated Tablet. Presentation: Unit., Trimetazidine. Concentration: 35Mg. Pharmaceutical Form: Coated Extended Release Tablet. Presentation: Unit., Valsartan, Concentration: 80 Mg. Pharmaceutical Form
Key Value
Tender Value
284,484 - BRL
Tender Documents
Global Tender Document
7ef6a9b4-fbe6-4ccc-9856-991dd0c6d3d1.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.